2026 Q3 Portfolio Activity
In 2026 Q3, CAXTON CORP maintained a portfolio of 13 distinct positions. The most significant new addition was NEW FORTRESS ENERGY INC, now representing 17.44% of the total fund value. They heavily accumulated shares in BLACKSTONE INC, increasing the position by 11.5%.
Position History
hover any row below to update
Loading…
Total Positions
13
Quarter
2026 Q3
Top Holding
SPCX (20.0%)
Top 10 Concentration
96.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13
CAXTON CORP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SPCX
SPACE EXPLORATI...
|
ETF | 20.04% | 24.03% |
#1
Prev: #1
|
8.5 |
—
|
1,093 | 41.9% |
P
S
|
3,699 | $557,959 |
$164.95
-13.0%
|
2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
N/A
NEW FORTRESS EN...
|
|
Preferred | 17.44% | — |
#2
Prev: #—
|
9.0 |
—
|
1,214 | — |
NEW
|
1,214 | $485,612 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
BRK/B
BERKSHIRE HATHA...
|
Financial Services | 15.00% | 20.35% |
#3
1
Prev: #2
|
7.0 |
—
|
85 | 11.3% |
P
S
|
839 | $417,659 | 2012 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TSLA
TESLA INC
|
Consumer Cyclical | 10.57% | — |
#4
Prev: #—
|
8.0 |
—
|
829 | — |
NEW
|
829 | $294,263 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VOO
VANGUARD INDEX ...
|
ETF | 9.51% | 12.58% |
#5
1
Prev: #4
|
6.3 |
—
|
39 | 11.5% |
P
S
|
378 | $264,716 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GOOGL
ALPHABET INC
|
Communication Services | 9.50% | 13.32% |
#6
3
Prev: #3
|
5.8 |
—
|
78 | 11.3% |
P
S
|
769 | $264,562 | 2019 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BX
BLACKSTONE INC
|
Financial Services | 7.17% | 10.16% |
#7
2
Prev: #5
|
4.9 |
—
|
183 | 11.5% |
P
S
|
1,780 | $199,534 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KYTX
KYVERNA THERAPE...
|
Healthcare | 3.02% | 5.94% |
#8
2
Prev: #6
|
2.2 |
—
|
no change | no change |
P
S
|
12,347 | $83,958 | 2012 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 2.06% | 4.26% |
#9
2
Prev: #7
|
1.8 |
—
|
no change | no change |
P
S
|
16,962 | $57,333 | 2012 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 2.05% | 3.12% |
#10
1
Prev: #9
|
1.3 |
—
|
-678 | -2.4% |
P
S
|
27,775 | $57,078 | 2012 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 1.41% | 3.92% |
#11
3
Prev: #8
|
1.1 |
—
|
-2,023 | -13.0% |
P
S
|
13,534 | $39,248 | 2012 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SABS
SAB BIOTHERAPEU...
|
Healthcare | 1.18% | — |
#12
Prev: #—
|
4.0 |
—
|
10,372 | — |
NEW
|
10,372 | $32,878 | 2012 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 1.05% | 2.34% |
#13
3
Prev: #10
|
1.4 |
—
|
no change | no change |
P
S
|
20,946 | $29,115 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-13 of 13 holdings